Skip to main content
Clinical Trials/NCT06753578
NCT06753578
Recruiting
Not Applicable

Effectiveness of an ACT-Based Cognitive Intervention on Quality of Life and Cognitive Function in Elderly Residents With MCI

Instituto de Investigación Marqués de Valdecilla1 site in 1 country215 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
Instituto de Investigación Marqués de Valdecilla
Enrollment
215
Locations
1
Primary Endpoint
Change in Quality of Life as measured by the QOL-AD scale
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study investigates the effects of an Acceptance and Commitment Therapy (ACT)-based cognitive intervention on Quality of Life (QOL) and cognitive function among elderly residents with Mild Cognitive Impairment (MCI) in long-term care settings. The study assesses immediate and long-term impacts on cognitive function, psychological flexibility, social engagement, and overall well-being through structured ACT-based training.

Detailed Description

This clinical trial explores the impact of an Acceptance and Commitment Therapy (ACT)-based cognitive intervention on Quality of Life (QOL) and cognitive function in elderly residents with Mild Cognitive Impairment (MCI) living in long-term care facilities. The intervention aims to promote psychological flexibility, which is a core process in ACT, and enhance the residents' ability to engage in meaningful activities despite cognitive limitations. Participants will engage in structured ACT-based training sessions that include mindfulness exercises, values clarification, and commitment strategies designed to improve cognitive engagement, reduce emotional distress, and foster greater social connection. The study measures both the immediate effects following the intervention and the long-term benefits at follow-up periods to evaluate sustained improvements in cognitive performance, psychological resilience, social involvement, and overall well-being. By focusing on cognitive and emotional strategies, the intervention seeks to empower elderly residents to live more fulfilling and value-driven lives, even in the face of cognitive decline associated with MCI.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
June 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Instituto de Investigación Marqués de Valdecilla
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Residents aged 65 and older diagnosed with MCI, able to provide informed consent, and residing in participating long-term care facilities.

Exclusion Criteria

  • Individuals with severe cognitive impairment, unstable medical conditions, or psychiatric diagnoses that would interfere with participation.

Outcomes

Primary Outcomes

Change in Quality of Life as measured by the QOL-AD scale

Time Frame: Baseline, post-intervention (12 weeks), and 6-month follow-up

Quality of Life will be assessed using the QOL-AD scale, a validated questionnaire for evaluating the quality of life in individuals with cognitive impairment. Changes in mean scores from baseline to each time point will be reported

Change in cognitive function as measured by the Mini-Mental State Examination (MMSE)

Time Frame: Baseline, post-intervention (12 weeks), and 6-month follow-up

Cognitive function will be evaluated using the MMSE, a widely used tool for cognitive assessment. Mean changes in scores from baseline to each time point will be analysed and reported

Secondary Outcomes

  • Psychological flexibility as measured by the Acceptance and Action Questionnaire (AAQ-II)(Baseline, post-intervention (12 weeks), and 6-month follow-up)
  • Social engagement as measured by a standardised engagement assessment tool(Baseline, post-intervention (12 weeks), and 6-month follow-up)

Study Sites (1)

Loading locations...

Similar Trials